Aligos Therapeutics to Announce 2nd Quarter 2025 Financial Results on August 6, 2025

Core Viewpoint - Aligos Therapeutics, Inc. is set to report its second quarter 2025 financial results on August 6, 2025, after the U.S. financial markets close [1] Company Overview - Aligos Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on developing best-in-class therapies for liver and viral diseases [2] - The company aims to improve patient outcomes through a science-driven approach and deep R&D expertise [2] - Aligos has a purpose-built pipeline targeting high unmet medical needs, including chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), and coronaviruses [2]